Home » relapsed and refractory market

Request Sample
1737

Order Summary

Report Title
relapsed-and-refractory-market Relapsed and Refractory Multiple Myeloma Treatment Market Relapsed and Refractory Multiple Myeloma (RRMM) Treatment Market By Treatment Modality (Immunomodulatory Drugs, Proteasome Inhibitors, Monoclonal Antibodies, CAR-T Cell Therapy, Bispecific Antibodies); By Line of Therapy (Second-Line Therapy, Third-Line and Beyond); By Route of Administration (Oral, Intravenous); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.
Report Id 91844395
License Type
Buy Now